(Q73011015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

P Marcellin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Trepo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Berthelot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J M Sanchez-Tapias

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Bassendine

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Tran

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Ouzan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Ring-Larsen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Lindberg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Enriquez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J P Benhamou

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

N Bindslev

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

803-813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Effects of prednisolone/azathioprine in chronic hepatitis B viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Successful re-treatment of an anti-interferon resistant polycythaemia vera patient with lymphoblastoid interferon-alpha N1 and in vitro studies on the specificity of the antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980282-0

7 January 2021

10.1016/S0168-8278(96)80282-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9007706%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference